;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • ProQR Therapeutics amends IPO

    ProQR Therapeutics B.V., Leiden, the Netherlands Business: Pulmonary Date announced: 2014-09-08 Type: IPO To be raised: Up to $81.3 million Shares: 6.3 million Price: $11-$13 Underwriters: Leerink Partners; Deutsche …

    Published on 9/15/2014
  • Ribomic amends IPO

    Ribomic Inc., Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date announced: 2014-09-08 Type: IPO To be raised: Up to Y2.8 billion ($26.2 million) Shares: 1.2 million Price: Y2,000-Y2,300 Underwriters: …

    Published on 9/15/2014
  • Vitae amends IPO

    Vitae Pharmaceuticals Inc., Fort Washington, Pa. Business: Cardiovascular, Endocrine/Metabolic, Neurology Date announced: 2014-09-08 Type: IPO To be raised: Up to $65 million Shares: 5 million Price: $11-$13 …

    Published on 9/15/2014
  • Aastrom completes follow-on

    Aastrom Biosciences Inc. (NASDAQ:ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy Date completed: 2014-09-11 Type: Follow-on Raised: $35 million Shares: 13.7 million Price: $2.55 Shares after offering: 21.7 million …

    Published on 9/15/2014
  • Affimed Therapeutics completes IPO

    Affimed Therapeutics N.V. (NASDAQ:AFMD), Heidelberg, Germany Business: Cancer, Inflammation, Antibodies Date completed: 2014-09-12 Type: IPO Raised: $56 million Shares: 8 million Price: $7 Shares after offering: 24 …

    Published on 9/15/2014
  • AM-Pharma completes venture financing

    AM-Pharma B.V., Bunnik, the Netherlands Business: Renal, Autoimmune Date completed: 2014-09-11 Type: Venture financing Raised: EUR12.2 million ($15.8 million) Investors: Gilde Healthcare Partners; AbbVie Inc. ; BB …

    Published on 9/15/2014
  • Edge Therapeutics completes venture financing

    Edge Therapeutics Inc., New Providence, N.J. Business: Neurology, Drug delivery Date completed: 2014-09-08 Type: Venture financing Raised: $3 million Investor: Hercules Technology Growth Capital Note: The company drew …

    Published on 9/15/2014
  • Euclises completes venture financing

    Euclises Pharmaceuticals Inc., St. Louis, Mo. Business: Cancer, Inflammation Date completed: 2014-09-09 Type: Venture financing Raised: $1.3 million Investors: Cultivation Capital; BioGenerator; Missouri Technology Corp…

    Published on 9/15/2014
  • Flex Pharma completes venture financing

    Flex Pharma Inc., Boston, Mass. Business: Neurology Date completed: 2014-09-08 Type: Venture financing Raised: $40 million Investors: Longwood Fund; Bessemer Venture Partners; EcoR1 Capital; Jennison Associates; …

    Published on 9/15/2014
  • Lq3 completes venture financing

    Lq3 Pharmaceuticals Inc., Morrisville, N.C. Business: Dental Date completed: 2014-09-10 Type: Venture financing Raised: $10 million Investor: Canaan Partners

    Published on 9/15/2014
  • NanoViricides completes warrant exercise

    NanoViricides Inc. (NYSE-M:NNVC), West Haven, Conn. Business: Infectious Date completed: 2014-09-08 Type: Warrant exercise Raised: $7.5 million Shares: 2.1 million Price: $3.50 Shares after offering: 56.8 million …

    Published on 9/15/2014
  • OnCore Biopharma completes venture financing

    OnCore Biopharma Inc., Doylestown, Pa. Business: Infectious Date completed: 2014-09-05 Type: Venture financing Raised: Not disclosed Investor: Not disclosed Note: The company raised an undisclosed amount in its first …

    Published on 9/15/2014
  • Zephyrus completes venture financing

    Zephyrus Biosciences Inc., Berkeley, Calif. Business: Proteomics, Supply/Service Date completed: 2014-09-10 Type: Venture financing Raised: $1.5 million Investors: Life Science Angels Inc.; Mission Bay Capital LLC; The …

    Published on 9/15/2014
  • Aurinia Pharmaceuticals financial update

    Aurinia Pharmaceuticals Inc. (TSX:AUP; NASDAQ:AUPH), Victoria, B.C. Business: Autoimmune, Transplant, Diagnostic Date announced: 2014-09-02 Note: Aurinia began trading on NASDAQ under the symbol "AUPH." The company will…

    Published on 9/15/2014
  • Avelas Biosciences financial update

    Avelas Biosciences Inc., San Diego, Calif. Business: Cancer, Diagnostic Date announced: 2014-09-10 Note: Avelas raised $550,000 in the second tranche of a series B round, bringing the total raised in the round to $7.4 …

    Published on 9/15/2014
  • BrainStorm financial update

    BrainStorm Cell Therapeutics Inc. (OTCQB:BCLID), New York, N.Y. Business: Neurology Date announced: 2014-09-09 Note: Brainstorm Cell Therapeutics implemented a 1-for-15 reverse stock split and began trading under the …

    Published on 9/15/2014
  • Clovis financial update

    Clovis Oncology Inc. (NASDAQ:CLVS), Boulder, Colo. Business: Cancer, Diagnostic Date announced: 2014-09-09 Note: Clovis raised $37.5 million through the sale of senior convertible notes following the exercise by …

    Published on 9/15/2014
  • Fennec Pharmaceuticals financial update

    Fennec Pharmaceuticals Inc. (TSX:FRX; OTCQB:ADHXD), Research Triangle Park, N.C. Business: Cancer, Other Date announced: 2014-09-03 Note: Adherex Technologies Inc. changed its name to Fennec, implemented a 1-for-3 …

    Published on 9/15/2014
  • Inovio financial update

    Inovio Pharmaceuticals Inc. (NYSE-M:INO), Blue Bell, Pa. Business: Cancer, Infectious Date announced: 2014-09-04 Note: Inovio will transfer its listing to NASDAQ under the ticker "INO" from the NYSE MKT, effective on …

    Published on 9/15/2014
  • Loxo financial update

    Loxo Oncology Inc. (NASDAQ:LOXO), Stamford, Conn. Business: Cancer Date announced: 2014-09-04 Note: Loxo raised $8.3 million through the sale of 642,000 shares at $13 to cover the overallotment from its Aug. 1 IPO, …

    Published on 9/15/2014
  • OrbiMed Advisors financial update

    OrbiMed Advisors, New York, N.Y. Business: Finance Date announced: 2014-09-09 Note: OrbiMed Advisors closed its second Asia fund with $325 million, above the firm's $300 million target. According to OrbiMed general …

    Published on 9/15/2014
  • Panther Biotechnology financial update

    Panther Biotechnology Inc. (OTCQB:PBYA), Evanston, Ill. Business: Cancer Date announced: 2014-09-08 Note: Panther plans to implement a 6-for-1 stock split. The effective date has yet to be determined. The company also …

    Published on 9/15/2014
  • PDL BioPharma financial update

    PDL BioPharma Inc. (NASDAQ:PDLI), Incline Village, Nev. Business: Antibodies Date announced: 2014-09-04 Note: PDL amended the conversion rates for its outstanding convertible senior notes in connection with its regular …

    Published on 9/15/2014
  • Polar Capital Holdings plc financial update

    Polar Capital Holdings plc, London, U.K. Business: Finance Date announced: 2014-09-12 Note: Polar Capital is fundraising for an open-ended global biotech fund focused on large cap companies. The Polar Capital Healthcare…

    Published on 9/15/2014
  • Retrophin financial update

    Retrophin Inc. (NASDAQ:RTRX), New York, N.Y. Business: Renal, Musculoskeletal, Pulmonary Date announced: 2014-09-08 Note: Retrophin filed a shelf registration covering the sale of up to $500 million of its securities. …

    Published on 9/15/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993